Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
about
Tuberculosis vaccines: beyond bacille Calmette-GuerinHeat shock proteins: stimulators of innate and acquired immunityIpr1 gene mediates innate immunity to tuberculosis.Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialPermutations of time and place in tuberculosisProtection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.Use of specific rRNA oligonucleotide probes for microscopic detection of Mycobacterium tuberculosis in culture and tissue specimens.Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.Cell-mediated immune responses in tuberculosis.Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosolNext generation: tuberculosis vaccines that elicit protective CD8+ T cellsMycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.Post-exposure vaccination against Mycobacterium tuberculosis.Tuberculosis: a problem with persistence.Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.Developing an improved vaccine against tuberculosis.Tuberculosis vaccine development: research, regulatory and clinical strategies.Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and controlTuberculosis vaccines: current status and future prospects.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.Tuberculosis subunit vaccines: from basic science to clinical testing.Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity.A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimenLessons for tuberculosis vaccines from respiratory virus infection.The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.TB vaccines: current status and future perspectives.Antituberculous vaccine development: a perspective for the endemic world.Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.
P2860
Q22242669-82568E34-FB5B-4B19-9535-644D3D8FC57EQ26829100-3B63BA5A-2922-4F6B-83C1-05BCE56047AAQ28585986-4D1BCF32-A0E9-4476-83D4-9ADF8F399193Q29620144-04F0CA2E-F7A2-479B-ABBF-358EB02142B3Q30378562-3A9FED4A-72E6-4B2F-A9EF-F7C25C4E72E5Q33353872-B0B33AA1-8B8B-4F9D-AAB3-81A2C41A9513Q33807147-CDE1BC4A-89E5-4EDF-A83A-04ACF6673CCFQ33848397-731BE509-73C7-4A4D-B080-EC2C31E0B492Q33946859-9E6CE832-501E-4CD7-BC98-3AB55CE6E3DEQ33999520-14D15DF3-211A-4A7B-AE42-09D08AE1FE26Q34044493-B0686EC3-B76C-449F-A71B-837BA1F2706AQ34073449-D1A488F5-6952-48A2-A57D-A1A025123C5FQ34554776-AA1B081D-693A-450B-ADAB-5084987207EFQ34852418-9F9EAEAE-627A-42CF-8A05-41C8EC990032Q34982062-3A4DCACD-1B2C-4189-98B7-2B3DCCB3418BQ35073776-8A4B3B8E-1C53-49DF-AB58-E94648164FEFQ35099708-7995EC10-7CE6-4436-B538-89F4DDA23FE6Q35099713-CB16A876-E1A8-48D0-9E6D-CC30E34AA5D8Q35101154-A6750A72-FF8D-4376-BD8D-54F52473A564Q35701685-8FF78F2B-991C-4FEA-B73F-DEDBA35A7598Q35754209-8D08EF06-0BE2-46AE-B02A-A400D9CF0A5DQ35791774-4097CB4B-5866-4B2A-894C-D5EE26652DAEQ35873788-B37ACAC6-1200-4538-B87D-C03219E7CC6CQ35960819-9AA1E69C-C9F6-4ECA-898A-BA5F572A1B59Q36090400-70375E08-0B52-463E-8F05-6FE1369126BFQ36361918-3972D505-3B9F-40BF-B46D-E7D84B2F74A6Q36458393-45FF64EE-DCE3-476C-8C01-5155A90DF24BQ36736465-D2FCF56A-6B5A-409A-9A87-F04DCE9F3E3BQ36811028-B6F943B6-B3B5-4BC8-9EF1-11553E362350Q36960497-C59CD79E-BDBE-4DA5-8151-6196CA695A43Q36977794-9A30BC53-ACEB-4C57-9215-3F6BAF1D329BQ37124690-C618183D-F2E7-410B-9D9F-95879F3227A5Q37242521-6036BA88-D6A2-4524-873C-9DF6C8266A5DQ37290093-A714AB4C-62E3-4E18-A0C5-5E4A50E8E44FQ37374958-E0C21DFE-1748-4C26-9CA4-CF7463B76B87Q37426754-9BE7FBD0-EFB6-4CA1-9DFA-DA73592773EBQ37435926-4EBD44A3-34CD-4BFC-914F-9A4E7884AAD4Q37622900-C2AB1288-A1F0-47D9-9C7D-93166AF7B33FQ38549766-AA3B249A-0A3F-4ECE-B6EA-1B12248C523FQ40014676-BD3C4A16-4CDF-4DCB-9675-0334CF35431D
P2860
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@en
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@nl
type
label
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@en
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@nl
prefLabel
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@en
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@nl
P2093
P2860
P1476
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
@en
P2093
Ian M Orme
Jennifer L Taylor
Oliver C Turner
Randall J Basaraba
P2860
P304
P356
10.1128/IAI.71.4.2192-2198.2003
P407
P577
2003-04-01T00:00:00Z